The mammalian target of rapamycin pathway and its role in molecular nutrition regulation
β Scribed by Jun Lian; Xiang-Hua Yan; Jian Peng; Si-Wen Jiang
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 925 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Mammalian target of rapamycin (mTOR) is a protein serineβthreonine kinase that functions as a central element in signaling pathway involved in control of cell growth and proliferation. mTOR exists in at least two distinct multiβprotein complexes, mTORC1 and mTORC2. mTOR kinase controls the translation machinery, in response to nutrients and growth factors, via activation of p70 ribosomal S6 kinase and inhibition of eukaryotic initiation factorβ4Eβbinding protein. In this report, we review the mTOR signaling pathway and its interaction with food intake, insulin resistance, lifespan and adipogenic regulation during the molecular nutrition regulation.
π SIMILAR VOLUMES
## Abstract Mammalian target of rapamycin (mTOR) mediates a signaling pathway that couples amino acid availability to S6 kinase (S6K) activation, translational initiation and cell growth rate, participating to a versatile checkpoint that inspects the energy status of the cell. The pathway is activa
## Abstract Curcumin (diferuloylmethane), a polyphenol natural product of the plant __Curcuma longa__, is undergoing early clinical trials as a novel anticancer agent. However, the anticancer mechanism of curcumin remains to be elucidated. Here we show that curcumin inhibited growth of rhabdomyosar
## Abstract Alterations of the Akt/mTOR pathway have been observed in numerous types of cancer, thus this pathway represents an exciting new target for molecular therapeutics. We investigated the expression of activated Akt (pβAkt) and mTOR (pβmTOR) in patients with adenocarcinoma of the cervix and